Saturday, August 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reiterates Buy Rating on Staar Surgical with Lower Price Target

Elaine Mendonca by Elaine Mendonca
February 28, 2024
in Breaking News
0
Financial literacy and school
0
SHARES
17
VIEWS
Share on FacebookShare on Twitter

On February 28, 2024, Mizuho analyst Anthony Petrone reiterated a Buy rating on Staar Surgical (NASDAQ: STAA) while revising the price target down to $45. This adjustment aligns with market expectations, as the average price target for Staar Surgical ranges from $36.50 to $44.38 among other analysts. Despite the lower price target, overall sentiment towards Staar Surgical remains optimistic, indicating strong belief in the company’s performance and future prospects.

STAA Stock Price Soars by 2.93% on February 28, 2024: Investors Keep a Close Eye on Positive Momentum

On February 28, 2024, STAA stock experienced a positive performance, with the price of shares increasing by $0.93 or 2.93% since the market last closed. The stock closed at $32.68, and further rose by $0.24 in after-hours trading.

Investors may be keeping a close eye on STAA to see if this positive momentum can be sustained in the coming days. It will be important for investors to continue monitoring STAA’s performance and any news or developments that could impact the stock price.

STAA Stock Analysis: Mixed Performance with Revenue Increase but Net Income Decrease

On February 28, 2024, STAA stock showed mixed performances based on the financial data provided by CNN Money. The total revenue for the company was reported at $322.42 million for the past year, with a significant increase of 13.37% compared to the previous year. However, the total revenue remained flat since the last quarter, indicating a potential plateau in growth.

In terms of net income, STAA reported a net income of $21.35 million for the past year, which represented a decrease of 44.92% compared to the previous year. On the other hand, the net income for the last quarter was reported at $7.76 million, showing a notable increase of 61.01% since the previous quarter. This suggests that the company may have implemented cost-cutting measures or improved operational efficiency to boost profitability in the short term.

Earnings per share (EPS) for STAA stock were reported at $0.43 for the past year, reflecting a decrease of 44.97% compared to the previous year. However, the EPS for the last quarter was reported at $0.16, showing a significant increase of 61.37% since the previous quarter. This indicates that the company may have taken steps to improve shareholder value in the short term.

Overall, STAA stock showed a mixed performance on February 28, 2024, with a strong increase in total revenue for the past year but a decrease in net income and EPS compared to the previous year. However, the company managed to improve profitability in the last quarter, which could potentially lead to a positive outlook for investors in the near future. Investors should closely monitor STAA’s financial performance and market trends.

Tags: STAA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Technology Artificial intelligence Markets and money

C3 AI Reports Strong Financial Results and Industry Expansion in Q3 Fiscal 2024

Mining Markets and money

Foremost Lithiums Proposal for Infrastructure Enhancement in Manitobas Snow Lake Region A Step Towards Sustainable Development

Adial Pharmaceuticals Expands Intellectual Property Portfolio for AD04 Treatment of Opioid Use Disorder

Recommended

Palantir Stock

Palantir Shares Face Valuation Pressures Despite Strong Earnings

9 months ago
BridgeBio Pharma Stock

BridgeBio Pharma Investors Await Critical Heart Drug Data

9 months ago
Ocugen Stock

Ocugen’s Fresh $130M Cushion Sets the Stage for a Data-Heavy July and a Pivotal Regulatory Filing

1 month ago
Airbnb Stock

Navigating Regulatory Headwinds and Innovation: Airbnb’s Strategic Crossroads

10 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

MSCI World ETF: Index Provider Rewrites the Rulebook for Fast-Moving Stocks

Airbus’ Paradox: A Slightly Smaller Forecast That Nobody Seems to Mind

Almonty Industries Rebounds From Index-Driven Exit as Tungsten Calculus Shifts Westward

OHB’s Two-Faced Half-Year: Record Orders Mask a Profit Squeeze That Spooked the Market

Trending

Nel ASA Stock
Analysis

Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding

by Jackson Burston
August 7, 2026
0

The Norwegian electrolyser maker Nel ASA is living a split-screen reality. Its order intake just exploded by...

SANDISK Stock

SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market

August 7, 2026
Bitcoin Stock

Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

August 7, 2026
Kioxia Stock

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

August 7, 2026
FALLBACK Stock

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

August 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding
  • SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market
  • Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com